Arbutus Biopharma Corp (ABUS)
3.46
+0.02
(+0.58%)
USD |
NASDAQ |
Nov 21, 16:00
3.46
0.00 (0.00%)
After-Hours: 18:28
Arbutus Biopharma Price: 3.46 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 3.53 | 3.540 | 3.42 | 3.44 | 626368.0 |
| Nov 19, 2024 | 3.51 | 3.520 | 3.42 | 3.49 | 910533.0 |
| Nov 18, 2024 | 3.64 | 3.68 | 3.49 | 3.52 | 1.064M |
| Nov 15, 2024 | 3.68 | 3.68 | 3.420 | 3.64 | 1.791M |
| Nov 14, 2024 | 3.66 | 3.81 | 3.625 | 3.63 | 1.141M |
| Nov 13, 2024 | 3.65 | 3.755 | 3.645 | 3.65 | 652430.0 |
| Nov 12, 2024 | 3.73 | 3.75 | 3.61 | 3.64 | 778875.0 |
| Nov 11, 2024 | 3.75 | 3.84 | 3.73 | 3.73 | 830022.0 |
| Nov 08, 2024 | 3.75 | 3.79 | 3.695 | 3.75 | 915560.0 |
| Nov 07, 2024 | 3.92 | 3.92 | 3.70 | 3.73 | 1.054M |
| Nov 06, 2024 | 3.85 | 3.955 | 3.60 | 3.92 | 1.546M |
| Nov 05, 2024 | 3.86 | 3.96 | 3.80 | 3.96 | 652311.0 |
| Nov 04, 2024 | 3.96 | 3.96 | 3.855 | 3.87 | 944765.0 |
| Nov 01, 2024 | 3.85 | 3.990 | 3.80 | 3.96 | 554161.0 |
| Oct 31, 2024 | 3.94 | 3.96 | 3.825 | 3.845 | 724803.0 |
| Oct 30, 2024 | 4.01 | 4.03 | 3.93 | 3.94 | 436084.0 |
| Oct 29, 2024 | 4.05 | 4.05 | 3.97 | 4.04 | 544851.0 |
| Oct 28, 2024 | 4.01 | 4.10 | 4.005 | 4.05 | 487431.0 |
| Oct 25, 2024 | 4.05 | 4.09 | 3.95 | 3.97 | 504380.0 |
| Oct 24, 2024 | 4.04 | 4.08 | 4.01 | 4.05 | 395812.0 |
| Oct 23, 2024 | 4.03 | 4.12 | 3.96 | 4.06 | 917672.0 |
| Oct 22, 2024 | 4.06 | 4.08 | 3.91 | 4.03 | 945270.0 |
| Oct 21, 2024 | 4.15 | 4.15 | 3.98 | 4.07 | 787630.0 |
| Oct 18, 2024 | 4.12 | 4.19 | 4.105 | 4.15 | 876479.0 |
| Oct 17, 2024 | 4.20 | 4.208 | 4.08 | 4.12 | 901012.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.9101
Minimum
Apr 03 2020
6.20
Maximum
Jul 23 2020
2.877
Average
2.83
Median
Oct 26 2020
Price Benchmarks
| Biomarin Pharmaceutical Inc | 63.44 |
| Amicus Therapeutics Inc | 9.485 |
| Ionis Pharmaceuticals Inc | 33.94 |
| GlycoMimetics Inc | 0.3212 |
| FibroGen Inc | 0.3862 |
Price Related Metrics
| PS Ratio | 92.54 |
| Price to Book Value | 6.134 |
| Earnings Yield | -12.43% |
| Market Cap | 655.64M |